These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

361 related items for PubMed ID: 15936376

  • 1. Enterobacter meningitis: organism susceptibilities, antimicrobial therapy and related outcomes.
    Foster DR, Rhoney DH.
    Surg Neurol; 2005 Jun; 63(6):533-7; discussion 537. PubMed ID: 15936376
    [Abstract] [Full Text] [Related]

  • 2. Third-generation cephalosporin resistance among Gram-negative bacilli causing meningitis in neurosurgical patients: significant challenges in ensuring effective antibiotic therapy.
    O'Neill E, Humphreys H, Phillips J, Smyth EG.
    J Antimicrob Chemother; 2006 Feb; 57(2):356-9. PubMed ID: 16368699
    [Abstract] [Full Text] [Related]

  • 3. Predictors of in-hospital mortality for bloodstream infections caused by Enterobacter species or Citrobacter freundii.
    Deal EN, Micek ST, Ritchie DJ, Reichley RM, Dunne WM, Kollef MH.
    Pharmacotherapy; 2007 Feb; 27(2):191-9. PubMed ID: 17253909
    [Abstract] [Full Text] [Related]

  • 4. Influence of third-generation cephalosporin resistance on adult in-hospital mortality from post-neurosurgical bacterial meningitis.
    Chang CJ, Ye JJ, Yang CC, Huang PY, Chiang PC, Lee MH.
    J Microbiol Immunol Infect; 2010 Aug; 43(4):301-9. PubMed ID: 20688290
    [Abstract] [Full Text] [Related]

  • 5. Effects of an alternative cefepime dosing strategy in pulmonary and bloodstream infections caused by Enterobacter spp, Citrobacter freundii, and Pseudomonas aeruginosa: a single-center, open-label, prospective, observational study.
    Deal EN, Micek ST, Reichley RM, Ritchie DJ.
    Clin Ther; 2009 Feb; 31(2):299-310. PubMed ID: 19302902
    [Abstract] [Full Text] [Related]

  • 6. Clinical characteristics of Stenotrophomonas maltophilia meningitis in adults: a high incidence in patients with a postneurosurgical state, long hospital staying and antibiotic use.
    Huang CR, Chen SF, Tsai NW, Chang CC, Lu CH, Chuang YC, Chien CC, Chang WN.
    Clin Neurol Neurosurg; 2013 Sep; 115(9):1709-15. PubMed ID: 23611735
    [Abstract] [Full Text] [Related]

  • 7. Clinical characteristics and predictors of mortality in patients with Enterobacter aerogenes bacteremia.
    Chang EP, Chiang DH, Lin ML, Chen TL, Wang FD, Liu CY.
    J Microbiol Immunol Infect; 2009 Aug; 42(4):329-35. PubMed ID: 19949757
    [Abstract] [Full Text] [Related]

  • 8. The clinical relevance of Enterobacter infections.
    Shlaes DM.
    Clin Ther; 1993 Aug; 15 Suppl A():21-8. PubMed ID: 8513457
    [Abstract] [Full Text] [Related]

  • 9. Antibiotic therapy for enterobacter meningitis: a retrospective review of 13 episodes and review of the literature.
    Wolff MA, Young CL, Ramphal R.
    Clin Infect Dis; 1993 Jun; 16(6):772-7. PubMed ID: 8329509
    [Abstract] [Full Text] [Related]

  • 10. Enterobacter bacteremia: Clinical features, risk factors for multiresistance and mortality in a Chinese University Hospital.
    Ye Y, Li JB, Ye DQ, Jiang ZJ.
    Infection; 2006 Oct; 34(5):252-7. PubMed ID: 17033748
    [Abstract] [Full Text] [Related]

  • 11. [Phenotypic and genotypic characterization of resistance to third-generation cephalosporins in Enterobacter spp].
    Bertona E, Radice M, Rodríguez CH, Barberis C, Vay C, Famiglietti A, Gutkind G.
    Rev Argent Microbiol; 2005 Oct; 37(4):203-8. PubMed ID: 16502641
    [Abstract] [Full Text] [Related]

  • 12.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 16. [Successful treatment of a patient with multidrug resistant Acinetobacter baumannii meningitis with high dose ampicillin-sulbactam].
    Sayin Kutlu S, Saçar S, Süzer T, Cevahir N, Okke D, Dirgen Caylak S, Turgut H.
    Mikrobiyol Bul; 2008 Apr; 42(2):353-8. PubMed ID: 18697435
    [Abstract] [Full Text] [Related]

  • 17. Differences in the changes in resistance patterns to third- and fourth-generation cephalosporins and piperacillin/tazobactam among Klebsiella pneumoniae and Escherichia coli clinical isolates following a restriction policy in a Greek tertiary care hospital.
    Petrikkos G, Markogiannakis A, Papaparaskevas J, Daikos GL, Stefanakos G, Zissis NP, Avlamis A.
    Int J Antimicrob Agents; 2007 Jan; 29(1):34-8. PubMed ID: 17189092
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Restriction of third-generation cephalosporin use decreases infection-related mortality.
    Du B, Chen D, Liu D, Long Y, Shi Y, Wang H, Rui X, Cui N.
    Crit Care Med; 2003 Apr; 31(4):1088-93. PubMed ID: 12682477
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 19.